Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adagene (DE:978)
FRANKFURT:978
Adagene (978) Stock Price & Analysis
0 Followers
978 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€1.01 - €3.66
Previous Close€2.44
Volume0.00
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$109.93M
Total Debt (Recent Filing)$22.13M
Price to Earnings (P/E)N/A
Beta0.42
Next Earnings
Aug 28, 2024EPS Estimate
-€0.38Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding55,145,839
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)2.13
Price to Sales (P/S)7.43
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.00
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€4.67Price Target Upside91.32% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Adagene News
PremiumCompany Announcements
Adagene Inc. Strikes Deal to Sell Depositary Shares
PremiumCompany Announcements
Adagene’s Breakthroughs Promise Future Growth
PremiumPress Releases
Adagene Announces Progress and Expansion of Clinical Collaboration Program for Masked, Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with KEYTRUDA® (pembrolizumab) to Demonstrate Further Efficacy in Patients with Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.00% Mutual Funds
15.47% Other Institutional Investors
84.53% Public Companies and
Individual Investors
978 FAQ
What was Adagene’s price range in the past 12 months?
Adagene lowest stock price was €1.01 and its highest was €3.66 in the past 12 months.
What is Adagene’s market cap?
Currently, no data Available
When is Adagene’s upcoming earnings report date?
Adagene’s upcoming earnings report date is Aug 28, 2024 which is in 125 days.
How were Adagene’s earnings last quarter?
Adagene released its earnings results on Mar 29, 2024. The company reported -€0.253 earnings per share for the quarter, beating the consensus estimate of -€0.394 by €0.141.
Is Adagene overvalued?
According to Wall Street analysts Adagene’s price is currently Undervalued.
Does Adagene pay dividends?
Adagene does not currently pay dividends.
What is Adagene’s EPS estimate?
Adagene’s EPS estimate is -€0.38.
How many shares outstanding does Adagene have?
Currently, no data Available
What happened to Adagene’s price movement after its last earnings report?
Adagene reported an EPS of -€0.253 in its last earnings report, beating expectations of -€0.394. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Adagene?
Currently, no hedge funds are holding shares in DE:978
---
Adagene Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
87.94%
12-Months-Change
Fundamentals
Return on Equity
-25.08%
Trailing 12-Months
Asset Growth
-24.06%
Trailing 12-Months
Company Description
Adagene
Adagene Inc is a clinical-stage immunotherapy company focused on the design and discovery of antibodies for the treatment of cancer.
---
978 Stock 12 Months Forecast
Average Price Target
€4.67
▲(91.32% Upside)
Technical Analysis
Adagene
―
Adaptimmune Therapeutics
―
ADMA Biologics
―
Adaptive Biotechnologies
―
Advaxis
―
Best Analysts Covering 978
1 Year
1 Year Success Rate
6/8 ratings generated profit
1 Year Average Return
+49.36%
reiterated a buy rating 21 days ago
Copying Arthur He CFA's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +49.36% per trade.
---